-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : UBS CUTS TARGET PRICE TO $354 FROM $550

Reuters·10/15/2026 14:21:18

Please log in to view news